Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

Anderson GG, Goller CC, Justice S, Hultgren SJ, Seed PC.

Infect Immun. 2010 Mar;78(3):963-75. doi: 10.1128/IAI.00925-09. Epub 2010 Jan 19.

2.
3.

Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.

Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ.

MBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16.

4.

Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Schwartz DJ, Chen SL, Hultgren SJ, Seed PC.

Infect Immun. 2011 Oct;79(10):4250-9. doi: 10.1128/IAI.05339-11. Epub 2011 Aug 1.

5.

OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.

Nicholson TF, Watts KM, Hunstad DA.

Infect Immun. 2009 Dec;77(12):5245-51. doi: 10.1128/IAI.00670-09. Epub 2009 Sep 21.

6.

Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis.

Cusumano CK, Hung CS, Chen SL, Hultgren SJ.

Infect Immun. 2010 Apr;78(4):1457-67. doi: 10.1128/IAI.01260-09. Epub 2010 Feb 1.

7.

Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.

Wright KJ, Seed PC, Hultgren SJ.

Infect Immun. 2005 Nov;73(11):7657-68.

8.

Maturation of intracellular Escherichia coli communities requires SurA.

Justice SS, Lauer SR, Hultgren SJ, Hunstad DA.

Infect Immun. 2006 Aug;74(8):4793-800.

9.

Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.

Hadjifrangiskou M, Gu AP, Pinkner JS, Kostakioti M, Zhang EW, Greene SE, Hultgren SJ.

J Bacteriol. 2012 Nov;194(22):6195-205. doi: 10.1128/JB.01012-12. Epub 2012 Sep 14.

10.

3-(2,6-difluorobenzamido)-5-(4-ethoxyphenyl) thiophene-2-carboxylic acid inhibits E.coli UT189 bacterial capsule biogenesis.

Noah JW, Ananthan S, Evans CW, Nebane NM, Rasmussen L, Sosa M, Tower NA, White EL, Seed P, Goller C, Datta A, Neuenswander B, Porubsky P, Maki BE, Rogers SA, Schoenen F, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Apr 16 [updated 2013 Mar 14].

11.

N-(pyridin-4-yl)benzo[d]thiazole-6-carboxamide inhibits E. coli UT189 bacterial capsule biogenesis.

Noah JW, Ananthan S, Evans CW, Nebane NM, Rasmussen L, Sosa M, Tower NA, White EL, Seed P, Goller C, Arshad M, Datta A, Neuenswander B, Porubsky P, Maki BE, Liu C, Rogers SA, Schoenen F, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Dec 17 [updated 2013 Apr 5].

12.

Filamentation by Escherichia coli subverts innate defenses during urinary tract infection.

Justice SS, Hunstad DA, Seed PC, Hultgren SJ.

Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19884-9. Epub 2006 Dec 15.

13.

Sialic acid and N-acetylglucosamine Regulate type 1 Fimbriae Synthesis.

Blomfield IC.

Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0015-2014.

PMID:
26185091
14.

Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli.

Sarkar S, Ulett GC, Totsika M, Phan MD, Schembri MA.

PLoS One. 2014 Apr 10;9(4):e94786. doi: 10.1371/journal.pone.0094786. eCollection 2014.

15.

Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression.

Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ.

Infect Immun. 2008 Jul;76(7):3337-45. doi: 10.1128/IAI.00090-08. Epub 2008 Apr 14.

16.

Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.

Danka ES, Hunstad DA.

J Infect Dis. 2015 Apr 1;211(7):1164-73. doi: 10.1093/infdis/jiu577. Epub 2014 Oct 21.

17.

Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ.

Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.

PMID:
21802164
18.

YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.

Lau ME, Loughman JA, Hunstad DA.

Infect Immun. 2012 Dec;80(12):4123-32. doi: 10.1128/IAI.00801-12. Epub 2012 Sep 10.

19.

The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.

Floyd KA, Mitchell CA, Eberly AR, Colling SJ, Zhang EW, DePas W, Chapman MR, Conover M, Rogers BR, Hultgren SJ, Hadjifrangiskou M.

J Bacteriol. 2016 Sep 9;198(19):2662-72. doi: 10.1128/JB.00030-16. Print 2016 Oct 1.

20.

Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80. doi: 10.1073/pnas.1500374112. Epub 2015 Feb 9.

Supplemental Content

Support Center